Investigating hearing changes in Alzheimer's disease

Hearing Biomarkers in Alzheimer's Disease

NIH-funded research Yale University · NIH-10906136

This study is looking at how hearing loss might be an early sign of Alzheimer's disease, using mice to find out if changes in hearing can help detect the disease sooner, which could lead to better ways to diagnose and treat it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University NIH-funded
Lab location1 site (New Haven, United States)
Project IDNIH-10906136 on NIH RePORTER

What this research studies

This research focuses on understanding how hearing loss may be an early indicator of Alzheimer's disease (AD) and its related dementias. By studying mouse models of AD, researchers aim to identify specific changes in hearing that could serve as biomarkers for early detection of the disease. The project will explore the relationship between auditory stimulation and the progression of AD, potentially leading to new methods for diagnosis and treatment. The findings could help in distinguishing between age-related hearing loss and hearing changes specifically caused by Alzheimer's.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals at risk for Alzheimer's disease, particularly those experiencing hearing loss.

Not a fit: Patients with advanced Alzheimer's disease or those without any hearing impairment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection of Alzheimer's disease, allowing for timely interventions that may slow disease progression.

How similar studies have performed: Previous studies have shown promising results in using sensory stimulation to influence Alzheimer's pathology, indicating that this approach may hold potential for success.

Where this research is happening

New Haven, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer disease detection
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.